What is Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co.,Ltd.'s (688505.SS) StockRank?

MoatMap's StockRank for Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co.,Ltd. (688505.SS) is 52/100, with a Hold signal. This is a composite score combining Quality (59), Value (40), and Momentum (43) factor ranks across MoatMap's 19,000+ stock universe.

Does Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co.,Ltd. have an economic moat?

Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co.,Ltd. (688505.SS) has a Quality factor score of 59/100. The Quality factor combines ROIC, Piotroski F-Score, and leverage — the financial fingerprints of a durable competitive advantage. A Quality score above 70 typically indicates a company with the financial characteristics of a moated business.

Is Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co.,Ltd. a buy, hold, or sell?

MoatMap's current signal for Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co.,Ltd. (688505.SS) is Hold, based on a StockRank of 52/100. Signals are derived mechanically from the StockRank composite and should be one input among many — combine with your own thesis on management, competitive position, and valuation.

What sector is Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co.,Ltd. in?

Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co.,Ltd. (688505.SS) operates in the Healthcare sector, specifically the Drug Manufacturers - Specialty & Generic industry (China).

Company Deep Dive

Business segments breakdown, earnings transcript analysis, management credibility scoring, competitive landscape, and scenario modelling.

Request Deep Dive(50 Feathers)

688505.SS

HOLDREMOVE

Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co.,Ltd. · Healthcare · China · $1.1B · Avg Vol: $4M/d

StockRank

P/E (TTM)

—

ROE

-6.9%

D/E

0.0x

Dividend %

—

Director Trades · 180d

None in 180d →

Buybacks · 180d

None in 180d →

AI CONVICTION THESIS

Shanghai Fudan-Zhangjiang Bio-Pharmaceutical is a specialty pharmaceutical firm. It is not a large-scale CDMO and does not benefit from the manufacturing bottleneck pricing power that defines our CDMO theme.

COMPANY DESCRIPTION

Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co., Ltd. researches, develops, and commercializes photodynamic therapies (PDT) and targeted oncology drugs. The company is a pioneer and market leader in photodynamic therapy in China, with proprietary drugs targeting skin diseases and cancers. It is an established specialty pharmaceutical company with a unique clinical niche and dual-listed status.

FINANCIAL SUMMARY

Year	2021	2022	2023	2024	2025	CAGR
Revenue	—	152M	126M	105M	101M	-12.7%
EPS	0.03	0.02	0.02	0.01	—	-42.5%
Shares	—	1.0B	1.0B	1.0B	1.0B	+1.4%
Debt	—	18M	3M	3M	2M	-51.0%
Equity	—	334M	348M	341M	313M	-2.1%
Op CF	—	24M	10M	-2M	21M	-5.1%
Inv CF	—	-14M	-7M	-3M	-2M	—
Fin CF	—	2M	-18M	-15M	-6M	—

PRICE (1M)-16.2%

SMA 50SMA 200

$0.99

RSI (14)

25.5

52W High

$1.73

From 52W High

0.6%

SCORE BREAKDOWN

Quality

ROIC

-7.2%36.9

ROE

-6.9%37.8

GP/Assets

24.7%55.9

Op. Margin

3.7%52.1

FCF/Assets

5.9%73.9

Piotroski

—55.8

Int. Cover

-50.0x6.5

D/E Ratio

0.01x91.5

Current Ratio

7.46x81.5

Value

P/E (TTM)

—N/A

EV/EBITDA

-56.8x94.4

P/FCF

362.8x21.8

P/B

3.3x36.1

P/S

10.8x24.9

Div Yield

—N/A

Momentum

52W High %

57%35.7

RS 6M

-28%44.5

SMA 50/200

0.89x31.5

EPS Rev 4W

—N/A

EPS Rev 12W

—N/A

EPS Improve

—N/A

Q Growth

189%91.8

FUNDAMENTALS

Market Cap

$1.1B

P/E (Forward)

—

Gross Margin

89.8%

SECTOR PEERS

Closest peers in Healthcare, ranked by industry match, size, and score similarity. Cross-listings of 688505.SS are excluded.

Ticker	Company	Mkt Cap	StockRank	Signal
688505.SS	Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co.,Ltd.(you)	$1.1B	52	HOLD
300119.SZ	Tianjin Ringpu Bio-Technology Co.,Ltd.	$1.1B	55	HOLD
688799.SS	Hunan Warrant Pharmaceutical Co.,Ltd	$975M	50	HOLD
300401.SZ	Zhejiang Garden Biopharmaceutical Co.,Ltd.	$984M	54	HOLD
600789.SS	Shandong Lukang Pharmaceutical Co.,Ltd.	$1.2B	48	HOLD
301393.SZ	Suzhou Highfine Biotech Co., Ltd.	$896M	55	HOLD
603538.SS	Ningbo Menovo Pharmaceutical Co., Ltd.	$1.6B	51	HOLD
2186.HK	Luye Pharma Group Ltd.	$1.1B	61	HOLD
300725.SZ	PharmaBlock Sciences (Nanjing), Inc.	$1.2B	60	HOLD
000813.SZ	Dezhan Healthcare Company Limited	$1.0B	42	HOLD

Peer medians: ROE 4.8% · P/E 27.8x · Gross margin 52.9%

Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co.,Ltd. (688505.SS) — Stock Score Summary

Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co.,Ltd. (688505.SS) has a MoatMap StockRank of 52/100 based on Quality (59/100), Value (40/100), and Momentum (43/100) factor scores. The current signal is HOLD. Shanghai Fudan-Zhangjiang Bio-Pharmaceutical is a specialty pharmaceutical firm. It is not a large-scale CDMO and does not benefit from the manufacturing bottleneck pricing power that defines our CDMO theme.

Key Financial Metrics

Price	$0.99
Market Cap	$1.1B
Price/Book	3.31
Return on Equity	-6.9%
Return on Invested Capital	-7.2%
Debt/Equity	0.63
Gross Margin	89.8%
Operating Margin	3.7%
Revenue Growth	-17.2%
Free Cash Flow	$3M

Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co.,Ltd. operates in the Drug Manufacturers - Specialty & Generic industry, part of the Healthcare sector (China).

Frequently Asked Questions

What is Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co.,Ltd.’s (688505.SS) StockRank?: MoatMap’s StockRank for Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co.,Ltd. (688505.SS) is 52/100, with a Hold signal. It is a composite of Quality (59), Value (40), and Momentum (43) factor ranks across MoatMap’s 19,000+ stock universe.
Does Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co.,Ltd. have an economic moat?: Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co.,Ltd. (688505.SS) has a Quality factor score of 59/100. The Quality factor combines ROIC, Piotroski F-Score, and leverage — the financial fingerprints of a durable competitive advantage. A Quality score above 70 typically indicates a company with the characteristics of a moated business.
Is Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co.,Ltd. a buy, hold, or sell?: MoatMap’s current signal for Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co.,Ltd. (688505.SS) is Hold, based on a StockRank of 52/100. Signals are derived mechanically from the StockRank composite and should be one input among many — combine with your own thesis on management, competitive position, and valuation.
What sector is Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co.,Ltd. in?: Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co.,Ltd. (688505.SS) operates in the Healthcare sector, specifically the Drug Manufacturers - Specialty & Generic industry (China).